JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1651
Krystal Biotech
KRYS
$9.91B
| $19.1M | ﹤0.01% |
238,409
+472
| +0.2% | +$37.1K |
2018 Q2
19 quarters
|
|
1652
Invesco MSCI Sustainable Future ETF
ERTH
$123M
| $19.1M | ﹤0.01% |
388,328
+11,615
| +3% | +$579K |
2021 Q4
5 quarters
|
|
|
EQC
1653
DELISTED
Equity Commonwealth
EQC
| $19.1M | ﹤0.01% |
920,197
-39,345
| -4% | -$913K |
2013 Q2
39 quarters
|
|
1654
Douglas Emmett
DEI
$1.61B
| $19M | ﹤0.01% |
1,544,021
+74,352
| +5% | +$1.08M |
2013 Q2
39 quarters
|
|
|
ISEE
1655
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $19M | ﹤0.01% |
782,096
+83,003
| +12% | +$1.82M |
2020 Q1
12 quarters
|
|
|
KKR.PRC
1656
DELISTED
KKR & Co. Inc. 6.00% Series C Mandatory Convertible Preferred Stock
KKR.PRC
| $19M | ﹤0.01% |
299,729
-243,105
| -45% | -$15.8M |
2021 Q4
5 quarters
|
|
|
WWE
1657
PUT
DELISTED
World Wrestling Entertainment
WWE
| $19M | ﹤0.01% |
+208,200
| New | +$17.8M |
2023 Q1
0 quarters
|
|
1658
Saic
SAIC
$5.32B
| $19M | ﹤0.01% |
176,679
+39,448
| +29% | +$4.16M |
2013 Q4
37 quarters
|
|
1659
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.24B
| $19M | ﹤0.01% |
204,406
-588,807
| -74% | -$54.1M |
2013 Q2
39 quarters
|
|
1660
WisdomTree Japan Hedged Equity Fund
DXJ
$7.19B
| $19M | ﹤0.01% |
267,977
-1,772,682
| -87% | -$122M |
2013 Q2
39 quarters
|
|
|
BNY
1661
CALL
Bank of New York Mellon
BNY
$97.5B
| $18.9M | ﹤0.01% |
416,900
+305,500
| +274% | +$14.8M |
2017 Q3
22 quarters
|
|
1662
Independent Bank
INDB
$3.78B
| $18.9M | ﹤0.01% |
288,404
+37,351
| +15% | +$2.86M |
2013 Q2
39 quarters
|
|
1663
Boise Cascade
BCC
$2.61B
| $18.9M | ﹤0.01% |
298,058
+4,182
| +1% | +$290K |
2013 Q2
39 quarters
|
|
1664
Erie Indemnity
ERIE
$11.6B
| $18.8M | ﹤0.01% |
81,240
+44,324
| +120% | +$10.6M |
2015 Q4
29 quarters
|
|
1665
Goodyear
GT
$1.35B
| $18.8M | ﹤0.01% |
1,706,426
+391,687
| +30% | +$4.34M |
2013 Q2
39 quarters
|
|
1666
Donaldson
DCI
$10.3B
| $18.8M | ﹤0.01% |
287,793
+58,141
| +25% | +$3.65M |
2013 Q2
39 quarters
|
|
|
ETRN
1667
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $18.8M | ﹤0.01% |
3,243,899
+836,878
| +35% | +$5.36M |
2018 Q4
17 quarters
|
|
1668
Dimensional US Core Equity 2 ETF
DFAC
$49.4B
| $18.7M | ﹤0.01% |
735,204
+131,384
| +22% | +$3.33M |
2021 Q2
7 quarters
|
|
1669
Helmerich & Payne
HP
$4.01B
| $18.7M | ﹤0.01% |
523,868
+186,122
| +55% | +$8.03M |
2013 Q2
39 quarters
|
|
|
BLD
1670
DELISTED
TopBuild
BLD
| $18.7M | ﹤0.01% |
89,859
+8,980
| +11% | +$1.74M |
2015 Q3
30 quarters
|
|
1671
CVR Energy
CVI
$5.72B
| $18.7M | ﹤0.01% |
570,458
+288,340
| +102% | +$9.24M |
2013 Q2
39 quarters
|
|
1672
CALL
Dow Inc
DOW
$20.6B
| $18.7M | ﹤0.01% |
340,800
+221,400
| +185% | +$12.5M |
2020 Q4
9 quarters
|
|
1673
ATI
ATI
$26.3B
| $18.7M | ﹤0.01% |
472,911
+176,296
| +59% | +$6.66M |
2016 Q4
25 quarters
|
|
1674
PUT
United Parcel Service
UPS
$79.2B
| $18.6M | ﹤0.01% |
96,100
+41,800
| +77% | +$7.67M |
2016 Q4
25 quarters
|
|
1675
First Bancorp
FBP
$4.14B
| $18.5M | ﹤0.01% |
1,624,032
-188,239
| -10% | -$2.48M |
2013 Q2
39 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.